Clinical Trials List
Protocol NumberMT14-TW24GBL102
Completed
2025-01-01 - 2027-06-30
Phase I
Recruiting1
-
Trial Applicant
MEDYTOX TAIWAN INC.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
13 participants
